JP2010540636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540636A5 JP2010540636A5 JP2010527993A JP2010527993A JP2010540636A5 JP 2010540636 A5 JP2010540636 A5 JP 2010540636A5 JP 2010527993 A JP2010527993 A JP 2010527993A JP 2010527993 A JP2010527993 A JP 2010527993A JP 2010540636 A5 JP2010540636 A5 JP 2010540636A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- animal
- cognitive function
- amount effective
- enhance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 claims 12
- 230000003920 cognitive function Effects 0.000 claims 10
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 8
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims 8
- 229940057917 medium chain triglycerides Drugs 0.000 claims 8
- 239000003963 antioxidant agent Substances 0.000 claims 4
- 235000019156 vitamin B Nutrition 0.000 claims 4
- 239000011720 vitamin B Substances 0.000 claims 4
- 229930003270 Vitamin B Natural products 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 230000002708 enhancing effect Effects 0.000 claims 3
- 230000032683 aging Effects 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 208000000044 Amnesia Diseases 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 208000022540 Consciousness disease Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 230000000386 athletic effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 230000001149 cognitive effect Effects 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 235000021323 fish oil Nutrition 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99766507P | 2007-10-04 | 2007-10-04 | |
| US60/997,665 | 2007-10-04 | ||
| PCT/US2008/011424 WO2009045481A1 (en) | 2007-10-04 | 2008-10-02 | Compositions and methods for enhancing cognitive function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010540636A JP2010540636A (ja) | 2010-12-24 |
| JP2010540636A5 true JP2010540636A5 (cg-RX-API-DMAC7.html) | 2011-11-17 |
| JP5931337B2 JP5931337B2 (ja) | 2016-06-08 |
Family
ID=40526561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010527993A Active JP5931337B2 (ja) | 2007-10-04 | 2008-10-02 | 認知機能を高める組成物及び方法 |
Country Status (16)
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1648952T3 (en) | 2003-06-03 | 2018-05-28 | The Us Gov As Represented By The Department Of Health And Human Services | Dietary supplements and therapeutic compositions comprising (R) -3-hydroxybutyrate derivatives |
| RU2500402C2 (ru) | 2008-01-04 | 2013-12-10 | Нестек С.А. | Композиции, включающие ненасыщенные жирные кислоты и соединения, высбождающие оксид азота, и их применение для усиления когнитивной функции и связанных с ней функций |
| CA2764038A1 (en) | 2009-05-29 | 2010-12-02 | The Trustees Of Columiba University In The City Of New York | Modulation of phospholipase d for the treatment of neurodegenerative disorders |
| CA2773523A1 (en) | 2009-09-11 | 2011-03-17 | Nestec S.A. | Compositions and methods for enhancing cognitive and related functions in animals |
| GB201002983D0 (en) * | 2010-02-22 | 2010-04-07 | Tdeltas Ltd | Nutritinal composition |
| DK2621503T3 (en) | 2010-09-29 | 2018-01-02 | Orkla Foods Sverige Ab | APPLICATION OF A FOOD PRODUCT INCLUDING VISCIO FIBER WITH A BENEFICIAL EFFECT ON COGNITIVE PERFORMANCE |
| EP2667882B1 (en) * | 2011-01-25 | 2020-08-12 | Société des Produits Nestlé S.A. | Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals |
| WO2012125020A1 (en) | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Method for treating neurotrauma |
| CA2830298C (en) | 2011-03-17 | 2016-08-16 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems comprising lecithin and methods of use thereof |
| BR112013023770B1 (pt) * | 2011-03-18 | 2020-12-15 | Société des Produits Nestlé S.A. | Composição útil para aliviar distúrbios relacionados à idade em um animal, e seu uso |
| RU2013154562A (ru) * | 2011-05-10 | 2015-06-20 | Нестек С.А. | Способы и композиции для сохранения безжировой массы тела в процессе похудения |
| JP2014519494A (ja) * | 2011-05-10 | 2014-08-14 | ネステク ソシエテ アノニム | 除脂肪量の増大を促進するための方法及び組成物 |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| US8551532B2 (en) | 2011-11-02 | 2013-10-08 | Kuwait University | Method of making an anti-inflammatory composition |
| US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
| US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
| US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
| US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
| US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
| US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
| US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
| US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| GB201304467D0 (en) | 2013-03-12 | 2013-04-24 | Tdeltas Ltd | Compound for use in protecting skin |
| US9750787B2 (en) * | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| KR101588247B1 (ko) * | 2013-04-17 | 2016-01-25 | 경희대학교 산학협력단 | 뇌졸중 또는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
| US20150086695A1 (en) * | 2013-09-23 | 2015-03-26 | Almendra Americas, LLC | Sweetener composition, sweetener products, and methods of sweetening |
| CN103609752B (zh) * | 2013-12-02 | 2016-05-25 | 内蒙古伊利实业集团股份有限公司 | 一种改善脑部认知功能的组合物及其制备方法与应用 |
| CA2963350A1 (en) * | 2014-10-10 | 2016-04-14 | Nestec S.A. | Compositions and methods for enhancing mobility or activity or treating frailty |
| CA3195997A1 (en) * | 2014-11-21 | 2016-05-26 | Christopher M. Mutti | Imaging system for object recognition and assessment |
| US10668041B2 (en) | 2014-12-08 | 2020-06-02 | Societe Des Produits Nestle Sa | Compositions and methods comprising medium chain triglycerides for treatment of epilepsy |
| AU2015358958B2 (en) * | 2014-12-08 | 2020-10-01 | Société des Produits Nestlé S.A. | Compositions and methods comprising medium chain triglycerides for treatment of epilepsy |
| EP3310349B1 (en) | 2015-06-22 | 2021-01-13 | Société des Produits Nestlé S.A. | Compositions and methods for enhancing neurogenesis in animals |
| CA3004996A1 (en) * | 2015-12-04 | 2017-06-08 | Nestec S.A. | Method for improving cognition |
| CN105663109A (zh) * | 2015-12-29 | 2016-06-15 | 浙江旭晨医药科技有限公司 | 甘油三酯类化合物在制备治疗神经退行性疾病药物中的应用 |
| GB2547903A (en) * | 2016-03-01 | 2017-09-06 | Dodson & Horrell Ltd | Antioxidant mix for learning |
| JP7523905B2 (ja) | 2016-09-29 | 2024-07-29 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 認知症でない患者における神経保護薬としての、ω３脂肪酸、一酸化窒素放出化合物及びビタミンＢ１２ |
| AU2017408873A1 (en) * | 2017-04-11 | 2019-08-29 | Societe Des Produits Nestle S.A. | Omega-3 fatty acid and vitamin D levels to identify and attenuate cognitive aging in individuals |
| MX2020004739A (es) | 2017-11-17 | 2020-09-21 | Hills Pet Nutrition Inc | Composiciones que comprenden acidos grasos de cadena media y poliinsaturados omega-3. |
| MX2020011923A (es) * | 2018-06-07 | 2021-01-15 | Nestle Sa | Metodos y composiciones para incrementar los cuerpos cetonicos en animales. |
| WO2019241728A1 (en) * | 2018-06-15 | 2019-12-19 | Youhealth Biotech, Limited | Composition and methods for modulation of elovl2 |
| JP7270160B2 (ja) * | 2018-08-07 | 2023-05-10 | 国立大学法人 香川大学 | 乳化イサダオイル |
| US12458617B2 (en) | 2019-05-24 | 2025-11-04 | Hill's Pet Nutrition, Inc. | Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis |
| CN114828648A (zh) * | 2019-12-19 | 2022-07-29 | 希尔氏宠物营养品公司 | 宠物食物组合物 |
| CN112662800B (zh) * | 2020-12-28 | 2022-12-20 | 广西大学 | 水稻耐冷主效qtl cts12的分子标记引物及其标记方法和应用 |
| CN119344377B (zh) * | 2024-12-27 | 2025-03-25 | 内蒙古伊利实业集团股份有限公司 | 一种有助于提升和/或改善个体社会行为的营养组合物及其应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2018A (en) * | 1841-03-26 | Joseph francis | ||
| US5780039A (en) * | 1992-04-23 | 1998-07-14 | Novartis Nutrition Ag | Orally-ingestible nutrition compositions having improved palatability |
| US5723446A (en) * | 1993-12-23 | 1998-03-03 | Nestec Ltd. | Enteral formulation designed for optimized nutrient absorption and wound healing |
| US5714472A (en) * | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
| US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
| US5977138A (en) * | 1996-08-15 | 1999-11-02 | Schering Corporation | Ether muscarinic antagonists |
| DE19757414A1 (de) * | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
| US7655423B2 (en) | 1999-06-14 | 2010-02-02 | Henry Ford Health System | Nitric oxide donors for inducing neurogenesis |
| ATE408402T1 (de) * | 1999-06-14 | 2008-10-15 | Ford Henry Health System | Stickstoffmonoxid-donoren zum induzieren von neurogenese |
| US20070179197A1 (en) * | 2000-05-01 | 2007-08-02 | Accera, Inc. | Compositions and methods for improving or preserving brain function |
| US20080009467A1 (en) * | 2000-05-01 | 2008-01-10 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| US20050002992A1 (en) * | 2003-06-17 | 2005-01-06 | Mccleary Edward Larry | Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
| AU2002336638A1 (en) * | 2001-10-12 | 2003-04-28 | Cornell Research Foundation, Inc. | Reversing or preventing premature vascular senescence |
| NL1019368C2 (nl) * | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| US20030113701A1 (en) * | 2001-12-13 | 2003-06-19 | William Gartner | Self-scoring method and apparatus for early self-screening of neurological disease |
| US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| US20060280776A1 (en) * | 2003-09-02 | 2006-12-14 | Masafumi Koide | Diet food |
| US8715717B2 (en) * | 2003-09-05 | 2014-05-06 | Hill's Pet Nutrition, Inc. | Composition for animal consumption |
| WO2005063050A1 (en) * | 2003-12-19 | 2005-07-14 | Abbott Laboratories | Method of increasing lean body mass and reducing body fat mass in infants |
| US20060002985A1 (en) * | 2004-07-02 | 2006-01-05 | Zicker Steven C | Compositions and methods for decreasing age-related deterioration in mental activities in companion animals |
| US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| CN1810257A (zh) * | 2005-05-26 | 2006-08-02 | 钟健琳 | 活脑素口服液 |
| CA2620024C (en) * | 2005-08-26 | 2014-11-18 | Nestec S.A. | Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| RU2413427C2 (ru) * | 2005-09-30 | 2011-03-10 | Нестек С.А. | Способы и композиция для улучшения когнитивной функции |
| NZ569235A (en) | 2005-12-15 | 2011-12-22 | Nestec Sa | Compositions and methods for preserving brain function using medium chain triglycerides |
| DK1800675T3 (da) * | 2005-12-23 | 2011-09-05 | Nutricia Nv | Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens |
| WO2009002145A1 (en) † | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
| RU2500402C2 (ru) * | 2008-01-04 | 2013-12-10 | Нестек С.А. | Композиции, включающие ненасыщенные жирные кислоты и соединения, высбождающие оксид азота, и их применение для усиления когнитивной функции и связанных с ней функций |
-
2008
- 2008-10-02 HU HUE08835957A patent/HUE037628T2/hu unknown
- 2008-10-02 CN CN200880110329A patent/CN101820754A/zh active Pending
- 2008-10-02 ES ES08835957T patent/ES2664777T5/es active Active
- 2008-10-02 TR TR2018/07131T patent/TR201807131T4/tr unknown
- 2008-10-02 CA CA2701179A patent/CA2701179C/en active Active
- 2008-10-02 JP JP2010527993A patent/JP5931337B2/ja active Active
- 2008-10-02 MX MX2010003568A patent/MX2010003568A/es active IP Right Grant
- 2008-10-02 PL PL08835957T patent/PL2194781T5/pl unknown
- 2008-10-02 EP EP08835957.5A patent/EP2194781B2/en active Active
- 2008-10-02 WO PCT/US2008/011424 patent/WO2009045481A1/en not_active Ceased
- 2008-10-02 AU AU2008307494A patent/AU2008307494B2/en active Active
- 2008-10-02 BR BRPI0818301-5A patent/BRPI0818301B1/pt active IP Right Grant
- 2008-10-02 NO NO08835957A patent/NO2194781T3/no unknown
- 2008-10-02 RU RU2010117221/15A patent/RU2507742C2/ru active
- 2008-10-02 US US12/734,014 patent/US20100292330A1/en not_active Abandoned
-
2010
- 2010-05-03 ZA ZA2010/03084A patent/ZA201003084B/en unknown
-
2013
- 2013-05-17 AU AU2013205916A patent/AU2013205916B2/en active Active
-
2016
- 2016-04-27 AU AU2016202685A patent/AU2016202685B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010540636A5 (cg-RX-API-DMAC7.html) | ||
| Ng et al. | Effects of dietary fish and vegetable oils on the growth, tissue fatty acid composition, oxidative stability and vitamin E content of red hybrid tilapia and efficacy of using fish oil finishing diets | |
| Jin et al. | Regulation of growth, tissue fatty acid composition, biochemical parameters and lipid related genes expression by different dietary lipid sources in juvenile black seabream, Acanthopagrus schlegelii | |
| RU2013146517A (ru) | Композиции и способы, пригодные для облегчения возрастных заболеваний | |
| JP2011508773A5 (cg-RX-API-DMAC7.html) | ||
| Austreng et al. | Digestibility of fat and fatty acids in rainbow trout and mink | |
| WO2008147562A3 (en) | Dietary formulations and methods for treatment of inflammation and other disorders | |
| RU2747879C2 (ru) | Композиции из рафинированного масла и способы их изготовления | |
| Kumar et al. | Omega-3 fatty acids effectively modulate growth performance, immune response, and disease resistance in fish against multiple stresses | |
| JP2014510530A5 (ja) | アルギニンレベルを増加させる栄養組成物 | |
| JP2014515011A5 (cg-RX-API-DMAC7.html) | ||
| JP2006501840A5 (cg-RX-API-DMAC7.html) | ||
| JP2014505702A5 (cg-RX-API-DMAC7.html) | ||
| Pratoomyot et al. | Comparison of effects of vegetable oils blended with southern hemisphere fish oil and decontaminated northern hemisphere fish oil on growth performance, composition and gene expression in Atlantic salmon (Salmo salar L.) | |
| JP2020503036A5 (cg-RX-API-DMAC7.html) | ||
| Dasilva et al. | A lipidomic study on the regulation of inflammation and oxidative stress targeted by marine ω-3 PUFA and polyphenols in high-fat high-sucrose diets | |
| NZ630210A (en) | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids | |
| JP2014514248A5 (cg-RX-API-DMAC7.html) | ||
| JP2014532773A5 (cg-RX-API-DMAC7.html) | ||
| ATE547005T1 (de) | Nährende speiseölzusammensetzungen und verfahren zu ihrer herstellung | |
| ES2376225T5 (es) | Genes de elongasa y usos de los mismos | |
| WO2015171960A1 (en) | Methods and compositions comprising 10-hydroxy-2-decenoic acid | |
| Gesto et al. | Early performance, stress-and disease-sensitivity in rainbow trout fry (Oncorhynchus mykiss) after total dietary replacement of fish oil with rapeseed oil. Effects of EPA and DHA supplementation | |
| WO2016040570A3 (en) | Dietary emulsion formulations and methods for using the same | |
| Aluko | Bioactive lipids |